Tacrolimus ointment is effective for facial and intertriginous psoriasis.

[1]  M. Lebwohl,et al.  Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. , 2003, Journal of the American Academy of Dermatology.

[2]  M. Rico,et al.  Tacrolimus clinical studies for atopic dermatitis and other conditions. , 2001, Seminars in cutaneous medicine and surgery.

[3]  P. Kerkhof.  New developments in the treatment of psoriasis. , 2001 .

[4]  S. Chartier,et al.  Tacrolimus in Dermatology , 2001, Journal of cutaneous medicine and surgery.

[5]  Sharon E. Albers,et al.  Textbook of Pediatric Dermatology , 2001 .

[6]  K. Nishioka,et al.  Topical tacrolimus is effective for facial lesions of psoriasis. , 2000, Acta dermato-venereologica.

[7]  F. Weissman,et al.  Pathophysiology and treatment of psoriasis. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[8]  A. Remitz,et al.  Tacrolimus ointment improves psoriasis in a microplaque assay , 1999, The British journal of dermatology.

[9]  L. Dubertret,et al.  Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. , 1998, Archives of dermatology.

[10]  P. Autio,et al.  Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. , 1998, The Journal of investigative dermatology.

[11]  J. Koo.  Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. , 1996, Dermatologic clinics.

[12]  E. Christophers.  Psoriasis: Mechanisms and entry points for possible therapeutic interventions , 1996, The Australasian journal of dermatology.

[13]  K. Wolff,et al.  Clearing of psoriasis by a novel immunosuppressive macrolide. , 1996, The Journal of investigative dermatology.

[14]  T. Ruzicka.  Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study , 1995 .

[15]  T. Starzl,et al.  Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. , 1992, Archives of dermatology.

[16]  D. Leung,et al.  Cellular and immunologic mechanisms in atopic dermatitis. , 2001, Journal of the American Academy of Dermatology.

[17]  I. Bekersky,et al.  Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. , 2001, Journal of the American Academy of Dermatology.

[18]  M. Lebwohl,et al.  Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas. , 2001, Journal of the American Academy of Dermatology.

[19]  E. Farber,et al.  The natural history of psoriasis in 5,600 patients. , 1974, Dermatologica.